CVS Health Corp. has agreed to pay $37.76 million to resolve a False Claims Act lawsuit alleging that its pharmacies ...

Rising Diabetes Rates and Digital InnovatioFuel European Insulin Pen Market Growth European Insulin Pen Market European ...

The "U.S. Insulin Pen Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been ...

Switzerland: Adults with type 1 diabetes using CGM and a smart insulin pen achieved higher time in range when they ...

Adults with type 1 diabetes using a continuous glucose monitoring system with a smart insulin pen attained a higher time in range if they responded more frequently to alerts for missed doses or high ...

A national pharmacy chain agreed to a $37.76 million settlement after federal investigators found it dispensed excess insulin ...

United States Attorney for the Southern District of New York, Jay Clayton, Special Agent in Charge of the New York Regional Office of the U.S. Department of Health and Human Services Office of the ...

The "U.S. Insulin Delivery Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" ...

Getting to grips with rising diabetes rates is arguably one of the most urgent tasks for South Africa's public healthcare system, but the setbacks keep coming. While some communities are facing ...

For a decade, CVS knew it was skirting rules meant to limit overprescribing but did nothing to stop, according to the ...

CVS to Pay $37.8 Million to Settle Overbilling Claims - CVS Pharmacy, Inc. agreed to pay $37.8 million to settle several lawsuits ...